Risk Classification | Definition |
---|---|
Very Low Risk | PSA<10ng/mL, Gleason=6, T1~T2a, biopsy positive core rate<34%, no cancer volume>50% of biopsy volume, PSA density<0.15ng/mL |
Low Risk | PSA<10ng/mL, Gleason=6, T1~T2a |
Intermediate Risk | 10ng/mL≤PSA<20ng/mL, or Gleason=7, or T2b~T2c |
Favorable Prognosis | Gleason=6 and 10ng/mL≤PSA<20ng/mL, or Gleason 3+4=7 and PSA<10ng/mL |
Unfavorable Prognosis | Gleason 3+4=7 and (10ng/mL≤PSA<20ng/mL or T2b~T2c), or Gleason 4+3=7 and PSA<20ng/mL |
High Risk | PSA≥20ng/mL, or Gleason=8~9, or ≥T3 |